Compare NSPR & BRFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSPR | BRFH |
|---|---|---|
| Founded | 2005 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.7M | 33.3M |
| IPO Year | 2009 | 2010 |
| Metric | NSPR | BRFH |
|---|---|---|
| Price | $0.72 | $1.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $4.00 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 116.6K | 3.7K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.53 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,310,000.00 | $211,467.00 |
| Revenue This Year | $57.98 | $115.22 |
| Revenue Next Year | $95.41 | $16.91 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 92.09 |
| 52 Week Low | $0.63 | $1.92 |
| 52 Week High | $2.93 | $6.08 |
| Indicator | NSPR | BRFH |
|---|---|---|
| Relative Strength Index (RSI) | 41.88 | 36.64 |
| Support Level | $0.69 | N/A |
| Resistance Level | $1.04 | $2.53 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 68.23 | 13.04 |
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Barfresh Food Group Inc develops, manufactures and distributes ready to blend frozen beverages, including smoothies, shakes and frappes for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, and without waste. Barfresh provides both a single serve solution and a bulk format solution, ideal for high-volume locations. It has seven flavors available as part of its standard line vanilla shake, caribbean smoothie, triple berry smoothie, caramel macchiato frappe, strawberry banana smoothie, mocha frappe and mango burst smoothie and has the development capabilities to deliver custom flavors.